Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Coaching for HCV and HIV [NA]
A completed clinical trial update on coaching for Hepatitis C and HIV infections; results posted in December 2022.
-
FDA approval · 2022-12-14FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Epclusa (velpatasvir/sofosbuvir) from Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections [Phase 2]
Phase 2 trial update for ISIS 14803-CS2 (ISIS 14803) administered IV in patients with chronic hepatitis C; study completed.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs [Phase 1, Phase 2]
Clinical trial update investigating addition of ISIS 14803 to peginterferon and ribavirin in chronic hepatitis C patients who did not adequa…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant [Phase 4]
Phase 4 trial updating immune response to grazoprevir/elbasvir when given before or after renal transplant in hepatitis C patients with rena…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection [Phase 3]
Phase 3 trial update on switching HIV therapy followed by Hepatitis C treatment in people co-infected with HIV and Hepatitis C; completed st…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1 [Phase 2]
Phase 2 trial updates the efficacy and safety of an all-oral combo (narlaprevir/ritonavir + sofosbuvir) in treatment-naïve chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Transplanting Hepatitis C Positive Organs [Phase 4]
Phase 4 clinical trial update on transplanting Hepatitis C–positive organs.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders [Phase 4]
Phase 4 trial update examining ribavirin with sofusbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C non-responders.
-
CLINICAL_TRIALS withdrawal · 2022-08-31Clinical Trial Update: HCV + to HCV - Kidney Transplant [Phase 4]
A Phase 4 clinical trial involving Hepatitis C and kidney failure in the context of kidney transplant was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P [Phase 3]
Phase 3 trial update comparing the 3D regimen versus G/P for treatment of acute hepatitis C; study completed.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant [Phase 4]
Phase 4 trial investigating direct-acting antiviral treatment in donor HCV-positive to recipient HCV-negative liver transplants; study termi…
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy [Phase 2]
Phase 2 clinical trial update for NOV-205 in hepatitis C patients who failed standard therapy has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis [Phase 4]
Phase 4 trial updating efficacy and safety of SOF/VEL with or without RBV and SOF/VEL/VOX for 12 weeks in hepatitis C patients with GT3b and…
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)
Clinical trial update reporting durability of virologic response and resistance patterns in patients with chronic hepatitis C previously tre…
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C [Phase 2]
Phase 2 trial evaluating ezetimibe for chronic hepatitis C; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant [Phase 4]
Phase 4 trial update on direct-acting antiviral (DAA) treatment for donor HCV-positive to recipient HCV-negative heart transplant; the study…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor [Phase 1, Phase 2]
Phase 1/2 clinical trial update on preventing transmission of hepatitis C from an HCV-viremic organ donor; study completed.
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: HCV Treatment Initiation During Acute Psychiatric Admission [Phase 4]
Phase 4 clinical trial update exploring initiation of hepatitis C treatment during acute psychiatric admission.
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study [Phase 3]
Phase 3 trial assessing Glecaprevir/Pibrentasvir with Sofosbuvir and Ribavirin in Hepatitis C patients who previously failed AbbVie studies;…
-
FDA approval · 2022-04-27FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Epclusa (velpatasvir/sofosbuvir) from Gilead Sciences, which expands the established use of the …
-
FDA approval · 2022-04-27FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Epclusa (velpatasvir and sofosbuvir) by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Pharmacist-led Hepatitis C Management [Phase 4]
Phase 4 clinical trial update on pharmacist-led management for hepatitis C, status not provided.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis [Phase 3]
Phase 3 trial evaluating Sofosbuvir/Velpatasvir fixed-dose combination for 12 weeks in adults with chronic Hepatitis C infection and compens…